Clinical Trial Update: Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic study evaluating nefopam 30 mg tablets in patients with acute rheumatic pain; status indicates not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatic Pain

Drugs mentioned

• Nefopam 30 mg tablets (nefopam)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Acute Rheumatic Pain | Phase 4 | Status: NOT_YET_RECRUITING